Executive Summary
France 2030 and the US CHIPS and Science Act represent the two most strategically coherent government interventions in semiconductor and advanced technology manufacturing launched in the early 2020s — yet they differ fundamentally in scope, mechanism, and ambition. The CHIPS Act writes a $52.7 billion check directly for chip manufacturing, research, and workforce development, while France 2030 spreads €54 billion across ten sectors including but not limited to semiconductors. Where CHIPS concentrates firepower on a single sector France views as a component of broader industrial sovereignty, France 2030 attempts something more sweeping: the comprehensive reindustrialization of a G7 economy. As of March 2026, the CHIPS Act has allocated the majority of its direct manufacturing grants to large projects — Intel in Ohio, TSMC in Arizona, Samsung in Texas, Micron in New York — while France 2030’s semiconductor investments have anchored around the STMicroelectronics-GlobalFoundries joint fab expansion in Crolles, Soitec’s wafer leadership, and specialty chip plays in silicon photonics and compound semiconductors. Neither plan is yet fully deployed; both face execution risks. But on the specific question of semiconductor sovereignty, the CHIPS Act has moved faster and at greater scale. On the broader question of industrial transformation, France 2030 has no American equivalent.
Budget and Scale
The numbers require careful unpacking. The CHIPS and Science Act, signed by President Biden in August 2022, authorized $280 billion in total — but $200 billion of that is aspirational science and research funding spread across a decade, subject to annual appropriations. The actual committed chips spending is $52.7 billion, divided between manufacturing incentives ($39B), R&D and workforce ($11B), and international partnerships ($2B). The CHIPS Office within the Department of Commerce has disbursed grants at a pace slower than the original timeline — as of early 2026, roughly 60-70% of manufacturing grants are committed but only a fraction fully disbursed, as projects face construction delays and permitting challenges.
France 2030 launched in October 2021 with a total of €54 billion — €34 billion in new commitments plus €20 billion rolled over from the fourth Programme d’Investissements d’Avenir (PIA4). Of this, semiconductors and electronics receive approximately €6 billion, part of the European Chips Act co-investment framework. The combined European Chips Act + France 2030 semiconductor commitment approaches €11-12 billion when national and EU-level programs are stacked, narrowing (but not closing) the gap with direct CHIPS Act investment.
Deployment rate: Both programs have struggled with speed. The CHIPS Act is hampered by US permitting processes, NEPA reviews, and the sheer complexity of building new semiconductor fabs. France 2030 faces European state aid notification requirements and the layered complexity of Bpifrance’s competitive call structure. Neither country is deploying at the pace originally advertised.
GDP context: France 2030 at €54 billion over nine years equals approximately 0.24% of French GDP annually. The direct CHIPS Act at $52.7 billion over five years equals approximately 0.04% of US GDP annually — a smaller relative commitment, reflecting that the US economy is nearly seven times France’s size.
Strategic Focus Areas
The CHIPS Act is laser-focused: it is a semiconductor act, not an industrial policy. Its explicit goal is to rebuild US chipmaking capacity after decades of offshoring to Asia, driven by the national security case for domestic supply chains and the shock of the 2021 chip shortage. It does not address hydrogen, nuclear, aviation, or biotech — those fall to the Inflation Reduction Act and other programs.
France 2030, by contrast, is a deliberate response to the question: “What industries must France master to remain a sovereign nation?” The answer spans ten sectors, with semiconductors as one of ten strategic priorities rather than the singular focus.
| Sector | France 2030 Allocation | CHIPS Act Coverage |
|---|---|---|
| Semiconductors | ~€6B | $52.7B direct |
| AI / Quantum | ~€2.5B | Included in $200B science |
| Nuclear Energy | ~€1B+ | Not covered |
| Green Hydrogen | ~€9B | Minimal coverage |
| EV / Batteries | ~€6B | Separate (IRA) |
| Aviation Decarb | ~€3B | Not covered |
| Health / Biotech | ~€7.5B | Not covered |
| Space | ~€2B | Not covered |
| Industrial Decarb | ~€5B | Separate (IRA) |
| Deep Sea / Food | ~€2B | Not covered |
The CHIPS Act’s concentration is both its strength and its limitation. It has mobilized over $300 billion in private co-investment for US chip manufacturing — a leverage ratio exceeding 5:1. France 2030’s semiconductor program has attracted significant private co-investment in Crolles and at Verkor/ACC battery gigafactories, but the total private leverage has been more modest given the broader distribution of public funds.
Governance and Implementation
The CHIPS Act is administered through the Department of Commerce’s CHIPS Program Office, with grants requiring extensive due diligence, national security reviews (particularly for foreign-connected companies), and clawback provisions preventing recipients from expanding capacity in China for ten years. The process is thorough but slow: major grants to TSMC, Intel, Samsung, and Micron took 18-24 months from application to announcement to disbursement.
France 2030 operates through a tiered governance structure: the SGPI (Secrétariat Général pour l’Investissement) sets strategy, Bpifrance operates most competitions and manages grants, while ADEME handles ecological transition projects and ANR manages research funding. This multi-operator structure creates coordination complexity but also specialized expertise. Bpifrance’s competitive call (appel à projets) model — requiring companies to compete for funding against defined criteria — is more rigorous than first-come-first-served incentive programs but slower than direct negotiated awards.
Key governance difference: The CHIPS Act can write a single $8.5 billion grant to Intel. France 2030 more typically disperses funds across many smaller beneficiaries through competitive calls, with fewer “national champion” mega-grants. The STMicro-GlobalFoundries Crolles expansion, backed by both France 2030 and the European Chips Act, represents the closest French equivalent to CHIPS Act flagship investments.
Key Beneficiaries
CHIPS Act winners:
- TSMC (Arizona fabs, $6.6B grant + $5B loan)
- Intel (Ohio and Arizona, $8.5B grant + $11B loan)
- Samsung (Texas expansion, $6.4B grant)
- Micron (New York HBM fab, $6.1B grant)
- GlobalFoundries (New York expansion, $1.5B)
- BAE Systems, Microchip Technology, SkyWater, Polar Semiconductor (specialty chips)
The CHIPS Act has clearly favored large, established manufacturers with proven manufacturing track records. Startups receive minimal direct grants, though CHIPS for America’s research programs support university-affiliated innovation hubs.
France 2030 semiconductor winners:
- STMicroelectronics / GlobalFoundries (Crolles 300mm expansion, billions in public support)
- Soitec (SOI wafer capacity expansion)
- Lynred (infrared detectors)
- Teledyne e2v (imaging sensors)
- Silicon photonics startups (multiple)
- GaN and SiC power semiconductor companies
France’s approach favors a wider ecosystem including mid-sized champions and startups alongside a few large-scale projects. The breadth creates more innovation activity but less concentrated manufacturing scale.
Results To Date
CHIPS Act (as of Q1 2026):
- Over $300 billion in private manufacturing co-investment announced
- Arizona TSMC N3/N4 fab on track for 2025-2026 production
- Intel Ohio fab facing construction delays, revised timeline to 2027+
- Approximately 20 new or expanded semiconductor manufacturing sites
- An estimated 50,000+ jobs created or committed
- First domestic advanced logic fabs in the US in decades
France 2030 semiconductors:
- STMicro Crolles 300mm expansion underway
- Soitec capacity expansion confirmed
- €3B+ committed to semiconductor ecosystem
- Multiple specialty chip programs funded
- France retains European leadership in FD-SOI, SiC, compound semiconductors
- Limited progress on leading-edge logic (2nm, 3nm) — not a France 2030 target
Both programs have accelerated semiconductor investment in their respective geographies. The CHIPS Act has succeeded in attracting the world’s most advanced chipmakers to the US. France 2030 has consolidated France’s position in specialty chips without attempting leading-edge competition.
Competitive Implications
The two plans are more complementary than directly competitive. France does not manufacture high-volume logic chips at 3nm or 5nm; those now go to Arizona and Taiwan. The US does not manufacture FD-SOI wafers; those come from Soitec in Bernin. The real competition is for the middle ground: automotive chips, power semiconductors, and mature-node manufacturing where both programs have overlapping interests.
The geopolitical framing also differs. The CHIPS Act contains explicit China guardrails — recipients cannot build new capacity in China or with certain Chinese entities for ten years. France 2030 operates within EU state aid rules that are less prescriptive about geopolitical restrictions, though the spirit of European technological sovereignty clearly underpins the strategy.
For investors, the key insight is that the CHIPS Act has already locked in the largest semiconductor companies’ US commitments. France’s window for attracting additional leading-edge fab investment is narrower than in 2021. The smarter French play — specialty differentiation — is exactly what France 2030’s semiconductor program pursues.
Analyst Assessment
On semiconductor manufacturing specifically, the CHIPS Act wins by a wide margin: larger budget, faster early progress on flagship projects, and has attracted all three of the world’s leading-edge chipmakers (TSMC, Samsung, Intel) to American soil for the first time. This is a strategic achievement of the first order.
On breadth and economic transformation, France 2030 covers vastly more ground. The US has no equivalent single program addressing nuclear, hydrogen, aviation decarbonization, and biotech simultaneously.
On governance quality, France 2030’s competitive-call model is arguably more rigorous than CHIPS Act direct grants — it requires companies to compete rather than negotiate. But CHIPS Act grants have moved faster for the largest projects.
On long-term industrial strategy, France 2030 will prove more durable because it addresses multiple pillars of French sovereignty simultaneously. The CHIPS Act is a point solution to a specific strategic problem (chip dependence on Asia). France 2030 is a comprehensive reindustrialization program.
The verdict: For semiconductor investors, the CHIPS Act is the superior instrument and has already delivered more measurable results. For investors seeking broad exposure to French industrial reindustrialization, France 2030 has no American equivalent.
Key Data Comparison Table
| Dimension | France 2030 | US CHIPS and Science Act |
|---|---|---|
| Total budget | €54B (10 sectors) | $280B authorized / $52.7B direct chips |
| Semiconductor allocation | ~€6B (via F2030 + European Chips Act: €11B+) | $52.7B direct |
| Annual deployment | ~€6B/year | ~$10-12B/year chips |
| % of GDP (annual) | ~0.24% | ~0.04% (chips only) |
| Governance | SGPI + Bpifrance + ADEME + ANR | CHIPS Program Office, Dept. of Commerce |
| Mechanism | Grants, equity, loans, guarantees | Grants + loans (CHIPS); tax credits (IRA) |
| Sector focus | 10 broad sectors | Semiconductors primarily |
| China restrictions | EU state aid rules | 10-year guardrail on China expansion |
| Private leverage | ~3-4x public funds | 5x+ public funds |
| Key beneficiaries | STMicro, Soitec, ecosystems | TSMC, Intel, Samsung, Micron |
| Leading-edge chips | Not targeted | Core focus (2nm, 3nm, advanced packaging) |
| Specialty chips | Core focus (FD-SOI, SiC, GaN) | Included but secondary |
| Jobs committed | 200,000+ (all sectors) | 50,000+ (chips manufacturing) |
| Timeline | 2021-2030 | 2022-2027 (direct funding window) |
| Status (Q1 2026) | ~€30B+ deployed | ~60-70% committed, 30-40% disbursed |